(Q30775480)

26 June 2017

1 reference

1 reference

title

Visceral leishmaniasis in pregnancy: a case series and a systematic review of the literature (English)

1 reference

26 June 2017

main subject

visceral leishmaniasis

1 reference

1 reference

5

Luigi Gradoni

1 reference

26 June 2017

Pasquale Pagliano

1

1 reference

26 June 2017

Novella Carannante

2

1 reference

26 June 2017

Marco Rossi

3

1 reference

26 June 2017

Marina Gramiccia

4

1 reference

26 June 2017

Francesco Saverio Faella

6

1 reference

26 June 2017

Giovanni Battista Gaeta

7

1 reference

26 June 2017

language of work or name

English

0 references

publication date

13 January 2005

1 reference

Journal of Antimicrobial Chemotherapy

26 June 2017

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

26 June 2017

volume

55

1 reference

26 June 2017

issue

2

1 reference

26 June 2017

page(s)

229-233

1 reference

Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda

26 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH538

Mediterranean visceral leishmaniasis in HIV-negative adults: a retrospective analysis of 64 consecutive cases (1995-2001).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH538

Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH538

U.S. Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH538

Clinical and experimental advances in treatment of visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH538

Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH538

Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH538

Immunology at the maternal-fetal interface: lessons for T cell tolerance and suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH538

Congenital visceral leishmaniasis: case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH538

Visceral leishmaniasis in a 6-week-old infant: possible congenital transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH538

Mediterranean visceral leishmaniasis in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH538

Visceral leishmaniasis during pregnancy treated with meglumine antimoniate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH538

Visceral leishmaniasis in pregnancy: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH538

Depressed natural killer cell cytotoxicity against Plasmodium falciparum-infected erythrocytes during first pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH538

Clinical spectrum of Leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH538

Embryotoxicity of meglumine antimoniate in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH538

21 January 2018

Identifiers

DOI

10.1093/JAC/DKH538

1 reference

26 June 2017

1 reference